Skip to main content
Clinical Trials/NCT00366717
NCT00366717
Completed
Not Applicable

Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy

Mackay Memorial Hospital1 site in 1 country20 target enrollmentStarted: June 2005Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1

Overview

Brief Summary

Cytomegalovirus (CMV) infects most of the world population. This study is to understand if chemotherapy will increase the chance of reactivating CMV. The results may help us in determining when treatment is needed and perhaps Why is it needed.

Detailed Description

Despite CMV reactivation has been clearly described in patients underwent transplantation, this phenomenon has not been studied in patients undergoing chemotherapy. Our purpose is to understand if CMV number increases in monocytic leukocytes during chemotherapy and how is the host response to that changes.

Virus load will be studied by quantitative PCR, host response will be studied by measuring patient's anti-CMV IgG, CMV-associated symptoms, serum IFN-r and TNF-a.

Study Design

Study Type
Observational
Observational Model
Defined Population
Time Perspective
Prospective

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • clinical diagnosis of any cancer
  • chemotherapy is needed for more than 6 months
  • age\>20 years old

Exclusion Criteria

  • those who do not agree to participate

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials